Cargando…

Correction: LINC01152 upregulates MAML2 expression to modulate the progression of glioblastoma multiforme via Notch signaling pathway

Detalles Bibliográficos
Autores principales:	Wu, Jianheng, Wang, Nannan, Yang, Ying, Jiang, Guangyuan, Mu, Qingchun, Zhan, Hui, Li, Fuyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460719/ https://www.ncbi.nlm.nih.gov/pubmed/34556630 http://dx.doi.org/10.1038/s41419-021-04106-8

Ejemplares similares

LINC01152 upregulates MAML2 expression to modulate the progression of glioblastoma multiforme via Notch signaling pathway
por: Wu, Jianheng, et al.
Publicado: (2021)

Leptin and Notch Signaling Cooperate in Sustaining Glioblastoma Multiforme Progression
por: Panza, Salvatore, et al.
Publicado: (2020)

Correction: NTRK1 Fusion in Glioblastoma Multiforme
Publicado: (2014)

Src kinase phosphorylates Notch1 to inhibit MAML binding
por: LaFoya, Bryce, et al.
Publicado: (2018)

CSL–MAML-dependent Notch1 signaling controls T lineage–specific IL-7Rα gene expression in early human thymopoiesis and leukemia
por: González-García, Sara, et al.
Publicado: (2009)

Prognostic utility of lncRNAs (LINC00565 and LINC00641) as molecular markers in glioblastoma multiforme (GBM)
por: Amer, Rehab G., et al.
Publicado: (2022)

Correction: Radiogenomic Mapping of Edema/Cellular Invasion MRI-Phenotypes in Glioblastoma Multiforme
por: Zinn, Pascal O., et al.
Publicado: (2012)

Correction: Podocalyxin Promotes Glioblastoma Multiforme Cell Invasion and Proliferation via β-Catenin Signaling
Publicado: (2015)

NOTCH2/NOTCH3/DLL3/MAML1/ADAM17 signaling network is associated with ovarian cancer
por: Jia, Dongyu, et al.
Publicado: (2019)

Correction: High LINC01605 expression predicts poor prognosis and promotes tumor progression via upregulation of MMP9 in bladder cancer
Publicado: (2020)

Cutaneous Papillomavirus E6 oncoproteins associate with MAML1 to repress transactivation and NOTCH signaling
por: Brimer, Nicole, et al.
Publicado: (2012)

Correction: Effect of anti-epileptic drugs on the survival of patients with glioblastoma multiforme: A retrospective, single-center study
por: Ryu, Jae Yeoul, et al.
Publicado: (2020)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

Notch and MAML-1 Complexation Do Not Detectably Alter the DNA Binding Specificity of the Transcription Factor CSL
por: Del Bianco, Cristina, et al.
Publicado: (2010)

Correction: Saponin 1 Induces Apoptosis and Suppresses NF-κB-Mediated Survival Signaling in Glioblastoma Multiforme (GBM)
por: Li, Juan, et al.
Publicado: (2014)

Genetic variant of MAML2 in the NOTCH signaling pathway and the risk of bladder cancer: A STROBE-compliant study
por: Shen, Yang, et al.
Publicado: (2020)

Correction: Gene expression and network-based analysis reveals a novel role for hsa-miR-9 and drug control over the p38 network in glioblastoma multiforme progression
por: Ben-Hamo, Rotem, et al.
Publicado: (2012)

Glioblastoma multiforme – an overview
por: Urbańska, Kaja, et al.
Publicado: (2014)

Incidentalomas to glioblastoma multiforme
por: Sachdev, Bobby, et al.
Publicado: (2014)

Correction to: Low LINC02147 expression promotes the malignant progression of oral submucous fibrosis
por: Chen, Jun, et al.
Publicado: (2022)

Apatinib for recurrent/progressive glioblastoma multiforme: A salvage option
por: Zhang, Hong-Hong, et al.
Publicado: (2022)

Correction to: Linc-ROR facilitates progression and angiogenesis of hepatocellular carcinoma by modulating DEPDC1 expression
por: Tian, Chuan, et al.
Publicado: (2021)

Tectal plate glioblastoma multiforme
por: Nemer, Michael D., et al.
Publicado: (2011)

Bilateral cystic glioblastoma multiforme
por: Kumar, Sushil, et al.
Publicado: (2013)

Glioblastoma Multiforme Stem Cells
por: Dimov, Irena, et al.
Publicado: (2011)

Atypical Presentation of Glioblastoma Multiforme
por: Al-Janabi, Wissam, et al.
Publicado: (2018)

Nanotechnology for Treatment of Glioblastoma Multiforme
por: Michael, Justin S., et al.
Publicado: (2018)

The complement system in glioblastoma multiforme
por: Bouwens van der Vlis, T. A. M., et al.
Publicado: (2018)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Survival Analysis of Glioblastoma Multiforme
por: Witthayanuwat, Supapan, et al.
Publicado: (2018)

Advances in Immunotherapy for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2017)

Targeted Nanotechnology in Glioblastoma Multiforme
por: Glaser, Talita, et al.
Publicado: (2017)

Prion Protein in Glioblastoma Multiforme
por: Ryskalin, Larisa, et al.
Publicado: (2019)

Current Immunotherapies for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2021)

Glioblastoma Multiforme Masquerading as Stroke
por: Remley, William, et al.
Publicado: (2021)

Advances in immunotherapy for glioblastoma multiforme
por: Mahmoud, Ahmad Bakur, et al.
Publicado: (2022)

CRTC1-MAML2 fusion-induced lncRNA LINC00473 expression maintains the growth and survival of human mucoepidermoid carcinoma cells
por: Chen, Zirong, et al.
Publicado: (2018)

Notch1 ablation radiosensitizes glioblastoma cells
por: Han, Na, et al.
Publicado: (2017)

Diagnostic Value of MAML2 Rearrangements in Mucoepidermoid Carcinoma
por: Thierauf, Julia C., et al.
Publicado: (2022)

Current progress in chimeric antigen receptor T cell therapy for glioblastoma multiforme
por: Marei, Hany E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vb3l3l8gdsb6n4a1omj59ljtb8